Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

568 results

Undilatable calcific lesion even after rotational atherectomy

19 Dec 2019

View this very uncommon case in which balloons do not expand even after a rather aggressive rotational atherectomy: a 43-year-old male with hypertension, smoking and dyslipidemia presents with total occlusion of proximal left anterior descending artery with fresh thrombus...

Author

Flavio Luciano Ribichini
Concetta Mammone

Author

Concetta Mammone
Undilatable calcific lesion even after rotational atherectomy

Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?

18 Oct 2019

Over the past year, an abundance of clinical evidence has emerged addressing the conceptually appealing and theoretically justified concept of dropping aspirin, rather than the P2Y12 antagonist, as part of antiplatelet regimens after percutaneous coronary intervention (PCI).

Authors :

M. Tomaniak, R. F. Storey, P. W. Serruys
EuroIntervention: newly-released article on aspirin

The future of medical device regulation in the European Union

New EU regulations on medical devices will come into force in 2020. Giulio Stefanini, Robert Byrne and Paul Piscoi discuss how new regulation is needed “to reflect the changes in the field over the last decades” and outline what this will mean for the safety of...

Medical device regulation in EU

Ticagrelor with or without aspirin in high-risk patients after PCI

07 Oct 2019

The TWILIGHT trial was designed to test the hypothesis that in patients undergoing PCI who are at high risk for ischemic or hemorrhagic complications and who have completed a 3-month course of DAPT with ticagrelor plus aspirin, continued treatment with ticagrelor monotherapy would be superior to ticagrelor...

Elad Asher

Reviewer

Elad Asher
Ticagrelor with or without aspirin in high-risk patients after PCI

Editor's picks: impactful articles in interventional cardiology

01 Oct 2019

Struggling to keep up with the mass of scientific information in interventional cardiology? On this page you will find a selection of recent articles published in major journals in the field - use it to guide your reading!

What's hot in interventional cardiology?

TWILIGHT: A randomized trial of ticagrelor monotherapy vs. ticagrelor-plus-aspirin beginning at 3 months in high-risk patients undergoing PCI

26 Sep 2019

At TCT 2019 in San Francisco - USA, Roxana Mehran presented the results of the TWILIGHT trial. Salvatore Brugaletta provides a summary of the key messages.

Author

Salvatore Brugaletta
TWILIGHT: A randomized trial of ticagrelor monotherapy vs. ticagrelor-plus-aspirin beginning at 3 months in high-risk patients undergoing PCI

PCR @ TCT 2019

17 Sep 2019

View reviews of a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2019 Transcatheter Cardiovascular Therapeutics Scientific Sessions. Check out the list here!

PCR @ TCT 2019

Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial

16 Sep 2019

GLOBAL LEADERS was a randomized, open-label, superiority trial in patients who underwent PCI with a biolimus A9-eluting stent for stable CAD or ACS...

Jacek Bil

Reviewer

Jacek Bil
Dejan Milasinovic

Reviewer

Dejan Milasinovic
Impact of long-term ticagrelor monotherapy following 1-month DAPT in patients who underwent complex PCI

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based antithrombotic regimen following successful coronary stenting in atrial fibrillation patients

09 Sep 2019

Francesco Costa, Italy, interviews Pascal Vranckx, PI of the ENTRUST-AF-PCI Trial

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based antithrombotic regimen following successful coronary stenting in atrial fibrillation patients

The best innovations in cardiovascular medicine

Catch up on the highlights from PCR Innovators Day with Ran Kornowski and Nicolo Piazza who describe some of the best innovations in cardiovascular medicine promoted at EuroPCR 2019. They explain why resilience is important for innovators and how it leads to improved outcomes for patients....

Best of PCR Innovators Day